| Demidov LV, Manziuk LV, Kharkevitch GY, et al. Adjuvant Fermented Wheat Germ Extract (Avemar()) Nutraceutical Improves Survival of High-Risk Skin Melanoma Patients: A Randomized, Pilot, Phase II Clinical Study with a 7-Year Follow-Up. [Journal Article] Cancer Biother Radiopharm 2008 Aug; 23(4):477-82. Abstract | Full Citation |
| Zigler M, Villares GJ, Lev DC, et al. Tumor immunotherapy in melanoma: strategies for overcoming mechanisms of resistance and escape. [Journal Article] Am J Clin Dermatol 2008; 9(5):307-11. Abstract | Full Citation | Find Related Articles |
| Cui CL, Chi ZH, Yuan XQ, et al. [Hepatic Intra-arterial Bio-chemotherapy for the Treatment of Melanoma Patients with Liver Metastasis: A Phase II Clinical Study.] [English Abstract, Journal Article] Ai Zheng 2008 Aug; 27(8):845-50. Abstract | Full Citation | Find Related Articles |
| Reschke M, Mihic-Probst D, van der Horst EH, et al. HER3 Is a Determinant for Poor Prognosis in Melanoma. [Journal Article] Clin Cancer Res 2008 Aug 15; 14(16):5188-97. Abstract | Full Citation | Find Related Articles |
| Dario A, Tomei G The safety of the temozolomide in patients with malignant glioma. [Journal Article] Curr Drug Saf 2006 May; 1(2):205-22. Abstract | Full Citation | Find Related Articles |
| Nagane M [Current topics of treatment for glioma and mechanism of drug resistance] [Journal Article] Gan To Kagaku Ryoho 2008 Jun; 35(6):918-25. Full Citation | Find Related Articles |
| Rosendahl M, Andersen CY, Ernst E, et al. Ovarian function after removal of an entire ovary for cryopreservation of pieces of cortex prior to gonadotoxic treatment: a follow-up study. [JOURNAL ARTICLE] Hum Reprod 2008 Jul 17. Abstract | Full Citation |
| Beier D, Röhrl S, Pillai DR, et al. Temozolomide preferentially depletes cancer stem cells in glioblastoma. [Journal Article, Research Support, Non-U.S. Gov't] Cancer Res 2008 Jul 15; 68(14):5706-15. Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Hauschild A, Dummer R, Ugurel S, et al. Combined treatment with pegylated interferon-alpha-2a and dacarbazine in patients with advanced metastatic melanoma: a phase 2 study. [JOURNAL ARTICLE] Cancer 2008 Jul 9. Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Fanti S, Castellucci P, Stefoni V, et al. Early relapse in a patient with Hodgkin's disease and negative interim FDG-PET. [JOURNAL ARTICLE] Ann Nucl Med 2008 Jun; 22(5):429-432. Abstract | Full Citation | Find Related Articles |
 |